IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Pivotal bioVenture Partners Investment Advisor LLC

Q2 2022 Holdings

Filed 2022-08-12 | 11 holdings | $12.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Arcutis Biotherapeutics Inc(ARQT)COM03969K108$12.1M569,04198.5%
Karuna Therapeutics IncCOM48576A100$111.5K881,4580.9%
Vaxcyte Inc(PCVX)COM92243G108$18.1K832,1660.1%
Rallybio CorpCOM75120L100$17.1K2,271,3110.1%
Inozyme Pharma IncCOM45790W108$12.7K2,661,1540.1%
Akouos IncCOM00973J101$8.4K1,794,0880.1%
Exscientia PLCADS30223G102$8.4K772,2850.1%
Fusion Pharmaceuticals IncCOM36118A100$3.9K1,560,9820.0%
Bolt Biotherapeutics Inc(BOLT1EUR)COM097702104$3.9K1,891,4670.0%
Vigil Neuroscience Inc(VIGL)COM92673K108$1.4K560,5950.0%
Aligos Therapeutics IncCOM01626L105$899743,2150.0%